my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
24-11-2010: Oxford Gene Technology (OGT) and Biotype Diagnostics GmbH announced the completion of a licence agreement granting Biotype access to OGT patents for the detection of DNA sequence variations. The licence, which will remain valid for the lifetime of the patents, provides Biotype with certain rights with respect to SNP genotyping.
Sue Sutton, VP Business Development at OGT, said: “OGT continues to develop its licensing programme and is pleased to license our sequence variation patents to Biotype. These patents are an important part of OGT’s broad patent portfolio and, together with Biotype’s microarray platform, gives customers access to a new, comprehensive way of detecting commercially important wood-rotting fungi.”
Wilhelm Zorgiebel, Executive Director at Biotype, commented: "We are pleased to enter into this licensing arrangement with OGT, a company that is recognised as being at the forefront of molecular technology. This agreement helps us to develop our own microarray technology platform for various applications in medicine and analytics. Our first product, which is completely unique in the market, is the Mycotype® BasidioQS Microarray Detection Kit, which allows the fast and sensitive, simultaneous analysis of the 27 most important wood-rotting basidiomycetes in Europe.”
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
OGT opens New York office and appoints US sales team
Oxford Gene Technology (OGT) announced that it has opened a new office in Tarrytown, New York to support and grow its cytogenetics arrays and next generation sequencing business in the US.The new office will enable OGT to provide hands-on technical support and training to its existing US cu ... more
OGT founder Professor Sir Ed Southern awarded the 2011 MRC Millennium Medal
Professor Sir Ed Southern, founder of Oxford Gene Technology (OGT) has been awarded the 2011 Medical Research Council (MRC) Millennium Medal. Sir Ed becomes one of only four researchers to have received the prize since it was inaugurated in the year 2000, which recognises an MRC-funded scie ... more
Oxford Gene Technology and Abcodia form Partnership
Oxford Gene Technology (OGT) has announced a collaborative agreement with Abcodia aimed at improving the early detection of pancreatic cancer. As part of this collaboration, Abcodia will provide access to its large prospective serum biobank, to harness samples taken from individuals up to 7 ... more
OGT Grants DNA Sequence Variation Licence to Biotype Diagnostics GmbH
Oxford Gene Technology (OGT) and Biotype Diagnostics GmbH announced the completion of a licence agreement granting Biotype access to OGT patents for the detection of DNA sequence variations. The licence, which will remain valid for the lifetime of the patents, provides Biotype with certain ... more
Biotype Diagnostic GmbH works continuously to develop and deliver unique molecular diagnostic solutions that set new performance and quality standards for test systems in clinical research and diagnostic. Today, our Mentype® products provide healthcare professionals with the vital informati ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
